The Multiple Myeloma Research Foundation (MMRF) helps accelerate the development of next generation multiple myeloma treatments to extend patient’s lives, and lead to a cure. MMRF brings treatment to multiple myeloma patients 60% faster than the average through collaboration with best in class partners in the US and Internationally. In the process, we are changing the way cancer research is conducted. MMRF, a 501(c)(3), is the number one private funder of multiple myeloma research in the United States.
Multiple myeloma is a type of blood cancer that affects the plasma cells. In multiple myeloma, malignant plasma cells accumulate in the bone marrow, crowding out the normal plasma cells that help fight infections. These malignant plasma cells then produce abnormal proteins (m protein) which may cause tumors, damage the kidneys, and impair immune system function. In some cases, the malignant cells may cause a single tumor, called a solitary plasmacytoma, but if multiple tumors are formed, then the disease is called multiple myeloma.
This year, we will be participating in the Multiple Myeloma Research Foundation (MMRF) Team for Cures 5K Walk/Run. We have committed to raising awareness and funds to accelerate finding a cure for multiple myeloma, which is the second most common blood cancer and is incurable. Your generosity truly makes a difference, as funds raised at this event have helped to:
- Nearly tripled patient survival
- Deliver six new treatments in less than a decade
- Launched over 55 new clinical trials
The Multiple Myeloma Research Foundation (MMRF) was established in 1998 as a 501(c)(3) non-profit organization by twin sisters Karen Andrews and Kathy Giusti, soon after Kathy's diagnosis with multiple myeloma. The mission of the MMRF is to relentlessly pursue innovative means that accelerate the development of next-generation multiple myeloma treatments to extend the lives of patients and lead to a cure.
Please support our participation in the MMRF Team for Cures 5K Walk/Run. Your donation will have a meaningful impact on the lives of thousands of patients and their families!The MMRF is bringing treatments to trial 60 percent faster than the industry standard and tripling life expectancy.THIS IS SCIENCE, NOT FICTION.The MMRF needs your support.History is being made, so we invite you to join us.
For more information, visit: